Literature DB >> 2574255

Systemic glutathione deficiency in symptom-free HIV-seropositive individuals.

R Buhl1, H A Jaffe, K J Holroyd, F B Wells, A Mastrangeli, C Saltini, A M Cantin, R G Crystal.   

Abstract

To find out whether systemic glutathione deficiency is associated with human immunodeficiency virus (HIV) infection, thus contributing to the immunodeficiency state, glutathione concentrations in venous plasma and lung epithelial lining fluid (ELF) of symptom-free HIV-seropositive and normal individuals were measured. Total and reduced glutathione concentrations in the plasma of the HIV-infected subjects were about 30% of those in the normal individuals. Concentrations of these substances in the ELF of HIV-infected subjects were about 60% of those in the controls. There was no correlation between ELF and plasma concentrations of total or reduced glutathione. Since glutathione enhances immune function, glutathione deficiency may contribute to the progressive immune dysfunction of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574255     DOI: 10.1016/s0140-6736(89)91909-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  103 in total

1.  Paracetamol overdose: an evidence based flowchart to guide management.

Authors:  C I Wallace; P I Dargan; A L Jones
Journal:  Emerg Med J       Date:  2002-05       Impact factor: 2.740

2.  N-acetyltransferases: pharmacogenetics and clinical consequences of polymorphic drug metabolism.

Authors:  S P Spielberg
Journal:  J Pharmacokinet Biopharm       Date:  1996-10

Review 3.  Acute poisoning: understanding 90% of cases in a nutshell.

Authors:  S L Greene; P I Dargan; A L Jones
Journal:  Postgrad Med J       Date:  2005-04       Impact factor: 2.401

4.  Plasma cysteine/cystine and glutathione/glutathione disulfide redox potentials in HIV and COPD patients.

Authors:  Walter H Watson; Jeffrey D Ritzenthaler; Paula Peyrani; Timothy L Wiemken; Stephen Furmanek; Andrea M Reyes Vega; Tom J Burke; Yuxuan Zheng; Julio A Ramirez; Jesse Roman
Journal:  Free Radic Biol Med       Date:  2019-07-29       Impact factor: 7.376

Review 5.  Lung cancer in HIV infected patients: facts, questions and challenges.

Authors:  J Cadranel; D Garfield; A Lavolé; M Wislez; B Milleron; C Mayaud
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

6.  Cystamine potently suppresses in vitro HIV replication in acutely and chronically infected human cells.

Authors:  A Bergamini; M Capozzi; L Ghibelli; L Dini; A Salanitro; G Milanese; T Wagner; S Beninati; C D Pesce; C Amici
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration.

Authors:  Erik R Kline; Dean J Kleinhenz; Bill Liang; Sergey Dikalov; David M Guidot; C Michael Hart; Dean P Jones; Roy L Sutliff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

8.  Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols.

Authors:  J E Freedman; B Frei; G N Welch; J Loscalzo
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication.

Authors:  H J Prochaska; Y Yeh; P Baron; B Polsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

10.  In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV.

Authors:  A Carr; B Tindall; R Penny; D A Cooper
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.